Session

PP 05 IBD (Posters)

IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE
IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

SEMI-AUTOMATED SEGMENTATION OF INFLAMED BOWEL WALL ON NONCONTRAST T2-WEIGHTED MRI FOR STREAMLINED VOLUMETRIC ASSESSMENT OF CROHN’S DISEASE
SEMI-AUTOMATED SEGMENTATION OF INFLAMED BOWEL WALL ON NONCONTRAST T2-WEIGHTED MRI FOR STREAMLINED VOLUMETRIC ASSESSMENT OF CROHN’S DISEASE

PP 05 IBD (Posters)  et al.

JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS
JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS

PP 05 IBD (Posters)  et al.

LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1
LONG-TERM CULTURING OF HEALTHY- AND ULCERATIVE COLITIS-PATIENT DERIVED COLON ORGANOIDS IS ASSOCIATED WITH DECREASED METHYLATION LEVEL OF LINE-1

PP 05 IBD (Posters)  et al.

THE IMPACT OF POINT-OF-CARE INTESTINAL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE PATIENTS
THE IMPACT OF POINT-OF-CARE INTESTINAL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE PATIENTS

PP 05 IBD (Posters)  et al.

CORTICOSTEROID-FREE REMISSION IN ANTI-TNF FAILED CROHN’S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB AS SECOND-LINE BIOLOGIC THERAPY: A REAL WORLD DATA REVIEW
CORTICOSTEROID-FREE REMISSION IN ANTI-TNF FAILED CROHN’S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB AS SECOND-LINE BIOLOGIC THERAPY: A REAL WORLD DATA REVIEW

PP 05 IBD (Posters)  et al.

SHOTGUN ANALYSIS OF GUT MICROBIOTA WITH BODY COMPOSITION AND LIPID CHARACTERISTICS IN CROHN'S DISEASE
SHOTGUN ANALYSIS OF GUT MICROBIOTA WITH BODY COMPOSITION AND LIPID CHARACTERISTICS IN CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

AUTOPHAGY/OXIDATIVE STRESS IMBALANCE IN STENOSING CROHN’S DISEASE PATIENTS: A PROOF-OF-CONCEPT STUDY
AUTOPHAGY/OXIDATIVE STRESS IMBALANCE IN STENOSING CROHN’S DISEASE PATIENTS: A PROOF-OF-CONCEPT STUDY

PP 05 IBD (Posters)  et al.

DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS
DISTINCTIVE MICROBIOTA AND DENDRITIC CELL ACTIVATION CHARACTERIZE THE APPENDIX OF ULCERATIVE COLITIS PATIENTS

PP 05 IBD (Posters)  et al.

NOTCH PATHWAY: THERAPEUTIC TARGET IN INTESTINAL FIBROSIS ASSOCIATED WITH CROHN'S DISEASE
NOTCH PATHWAY: THERAPEUTIC TARGET IN INTESTINAL FIBROSIS ASSOCIATED WITH CROHN'S DISEASE

PP 05 IBD (Posters)  et al.

BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS
BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS

PP 05 IBD (Posters)  et al.

IBD PATIENTS SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE PORTUGUESE COHORT OF THE IBD PODCAST STUDY
IBD PATIENTS SHOW SIGNS OF RELEVANT DISEASE ACTIVITY – RESULTS FROM THE PORTUGUESE COHORT OF THE IBD PODCAST STUDY

PP 05 IBD (Posters)  et al.

ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM
ACCURACY OF PANMAYO ENDOSCOPIC SCORE IN PREDICTING LONG-TERM DISEASE OUTCOMES IN ULCERATIVE COLITIS– A PROMISING SCORING SYSTEM

PP 05 IBD (Posters)  et al.

IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING
IMMUNE AND NON IMMUNE CHANGES FOLLOWING FMT IN EXPERIMENTAL COLITIS: EMERGING PATHWAYS OF FMT-DERIVED MUCOSAL HEALING

PP 05 IBD (Posters)  et al.

ANTI-INFLAMMATORY EFFECT OF LMT503, A MODULATOR OF CELL METABOLISM, AMELIORATES MURINE ADOPTIVE T CELL TRANSFER-INDUCED COLITIS
ANTI-INFLAMMATORY EFFECT OF LMT503, A MODULATOR OF CELL METABOLISM, AMELIORATES MURINE ADOPTIVE T CELL TRANSFER-INDUCED COLITIS

PP 05 IBD (Posters)  et al.

A HIGHER TH2/TREG RATIO MAY BE A MARKER OF REFRACTORY ULCERATIVE COLITIS WITH LONGER DISEASE DURATION AND FREQUENT USE OF STEROIDS AND/OR IMMUNOSUPPRESSANTS, WHEREAS HLA GENOTYPE IS NOT
A HIGHER TH2/TREG RATIO MAY BE A MARKER OF REFRACTORY ULCERATIVE COLITIS WITH LONGER DISEASE DURATION AND FREQUENT USE OF STEROIDS AND/OR IMMUNOSUPPRESSANTS, WHEREAS HLA GENOTYPE IS NOT

PP 05 IBD (Posters)  et al.

EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?
EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?

PP 05 IBD (Posters)  et al.

IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER
IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER

PP 05 IBD (Posters)  et al.

MACHINE LEARNING APPROACH TO PREDICT TREATMENT OUTCOMES OF ANTI-TUMOR NECROSIS FACTOR -Α ANTIBODY AGENTS FOR PATIENTS WITH CROHN’S DISEASE
MACHINE LEARNING APPROACH TO PREDICT TREATMENT OUTCOMES OF ANTI-TUMOR NECROSIS FACTOR -Α ANTIBODY AGENTS FOR PATIENTS WITH CROHN’S DISEASE

PP 05 IBD (Posters)  et al.

Item 81 - 100 / 826
1 2 3 4
5
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42